HIDE at First Glimpse- An Early Penny Pick Alert

HIDE at First Glimpse Early Penny Pick Alert (Pk) HIDE was brought to our attention from the increasing activity that we noticed over the past few weeks. After doing our DD and looking over the chart we feel positive that HIDE could make a major move to the upside very soon. We highly suggest that everyone do their research on this hidden gem and keep a very close eye on it in the mean time. With over 100 years of combined telecom experience, Nucentcom Inc has established undisputable trust and long lasting relationships with numerous corporations across the globe. To meet the demands ..read more

BullQuake- ZIPZ, LVCA, & AEZS Afternoon Recap

We first alerted ZIPZ to our members at 0.0005 yesterday afternoon. Since our alert ZIPZ has Bullishly Roared up Over 100%, testing 0.0013 for the HOD. LVCA- We alerted this one premarket, during mid afternoon LVCA had already made our members over 12%. AEZS- We alerted our members on Twitter mid at 1.57 about the potential for a rebound, since then AEZS has climbed to a high of 1.77! We firmly believe AEZS could start a bullish uptrend headed into the ASCO, which is scheduled for early June. Please remember to do your due diligence. To view our full disclaimer please click here

BullQuake- Our Afternoon Penny Pick is Zippi Networks, Inc. (publicly traded: ZIPZ.PK)

Our afternoon penny pick alert is ZIPZ which is currently trading at 0.0005. Over the past few weeks ZIPZ has been brought down to all time lows thanks to a disgruntled share holder. Now that he has cashed out ZIPZ looks ready to move once again. It appears a nice bottom has formed between 0.0005 – 0.0006, with major updates expected shortly ZIPZ could make a quick push over 0.001. Remember don’t trade like a greedy pig, always remember to lock your profits! About ZIPZ Zippi Networks, Inc. (publicly traded: ZIPZ.PK), headquartered in San Jose, Calif., has created a revolutionary business process ..read more

Breaking News: (AEZS) Aeterna Zentaris: Data on Lead Anticancer Compounds Perifosine and AEZS-108 to be Presented at Upcoming ASCO Annual Meeting

Press Release Source: AETERNA ZENTARIS INC. On Friday May 21, 2010, 8:35 am QUÉBEC CITY, May 21 /PRNewswire-FirstCall/ – Aeterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), (the “Company”) a late-stage drug development company specialized in oncology and endocrine therapy, today announced that data on two of its lead anticancer compounds, perifosine and AEZS-108, will be presented at the upcoming Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4 through 8, 2010 at McCormick Place in Chicago. Two posters on perifosine, Aeterna Zentaris’ novel, ..read more

Cytori Therapeutics (NASDAQ: CYTX) Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial

Cytori Therapeutics (NASDAQ: CYTX) Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells for the treatment of heart attacks showed a substantial reduction in the size of injury to the heart, an improvement in the amount of blood supply to the heart muscle, and a corresponding functional improvement in the amount of blood the heart can pump. Based on positive safety and feasibility outcomes, and the biological, physiological and functional effects from this pilot study, plans ..read more

Q1/10 Results Out Preformed Expectations, Cytori Therapeutics (CYTX)

Q1/10 total revenue  was $4.4 M.  The net loss for Q1/10 was $2.447 M or ($0.06) per share, which surpassed all expectations from leading analysts who estimated a 0.16 per share loss. Q1/10 product revenues were $2.3 M from Celution® and StemSource® sales in Europe, Asia and the US  (representing 19% product revenue growth over Q1/09 of $1.9 M and 80% growth over Q4/09) and $2.1 M in development revenue . The cumulative number of revenue generating systems grew to 110 in Q1/10 (compared to 59 in Q1/09). In addition, 342 consumables, including 261 re-orders were shipped (compared to 241 total consumables in Q1/09) and 164 ..read more

CYTX- A Stock Pick That Mustn’T Miss!!

CYTX- A Stock Pick That Mustn’T Miss!! CYTX- Put this one on your watch list, Cytori Therapeutics will announce the results of their Chronic Heart Ischemia trials on May 6 & 7th. We feel CYTX could be trading very bullishly up until then, if the results are positive the stocks pps could go orbital! Be ready!! About Cytori Cytori is an emerging leader in regenerative medicine, providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution(R) System family of medical devices and instruments is being sold ..read more

Do we have your Attention Now? Our Members Continue to Make Huge Profits!

Our members continue to make some Major Profits! Here are some of our most recent alerts: HIRU hit 0.038 on Record Volume for a HOD after Our Alert at 0.02!! ABK- We alerted our members at 0.65 then it ran to 1.19! Over a 90% Return! GETA- We alerted our members at 0.06 a week later she ran to a Monstrous high of 0.20! That’s Over 210%! EXPU- We alerted our members at 0.055 shortly after this beauty was trading in the low 0.20’s!! FRHV- We alerted our members at 0.002 then it ran to over 0.15 per share!! BBI- We alerted our ..read more

HIRU is Our Next Big Pick! Grab a Position Early for the Biggest Gains!!

HIRU is Our Next Big Pick! Grab a Position Early for the Biggest Gains!! Hiru Corporation represents Jiangxi RongYu Pharmaceutical Group Co., Ltd., one of the top producers of Chinese herbs for the naturopathic industry in China. Jiangxi RongYu Pharmaceutical Group Co., Ltd. focuses on the production of traditional Chinese naturopathic medicines outside Fuzhou City, China. The company’s modern facility and technology earned national GMP (Good Manufacturing Practice) certificate in 2006, and its sustainable agricultural approach earned the company GAP (Good Agricultural Practice) certificate. The company is the largest in Jiangxi Province to hold the GAP certificate. Jiangxi RongYu Pharmaceutical Group Co., ..read more

What An Explosive Week for Our Subscribers! Members who’ve been following our alerts closely are constantly bringing in HUGE profits!

What An Explosive Week for Our Subscribers! Members who’ve been following our alerts closely are constantly bringing in HUGE profits !! We’ve been getting a ton of emails lately thanking us for our fantastic work. We greatly appreciate all of the positive feedback from our followers and we look forward to always hearing more! ABK- Alerted at 0.65 ran to 1.19! Over a 90% Return! GETA- Alerted at 0.06 Ran to a Monstrous high of 0.20! That’s Over 210%! BBI- Alerted at 0.289 10 minutes later 0.32’s were being hit for a gain of about 10%! For the Hottest intraday and premarket stock alerts keep ..read more

Next Page »